Axio BioPharma

@axio_biopharma

Madison, Wisconsin

https://www.axiobiopharma.com/

Biotechnology Research

Overview

About Axio BioPharma

Axio BioPharma is a Contract Development and Manufacturing Organization (CDMO) transforming biopharmaceutical manufacturing. We accelerate the development of mammalian-expressed recombinant proteins, with a focus on monoclonal antibodies (mAbs). Our approach significantly reduces the timeline from lab research to clinical manufacturing, enabling faster delivery of critical therapies. At Axio BioPharma, we are committed to reducing the time it takes to get life-saving therapies to patients.

Headquarters

Madison, Wisconsin

Website

https://www.axiobiopharma.com/

Company Size

11-50 employees

Industry

Biotechnology Research

Company Type

Privately Held

Founded

2024

Specialties

Biologics, Mammalian Expression, Contract Development, Contract Manufacturing, Antibodies, Protein Purification, CDMO, MKLP, Recombinant Proteins, Process Development, AI, High-Throughput Screening, Bioprocessing, Mammalian Cell Culture, Cell Line Development , Therapeutic Antibodies, Biomanufacturing, CMC Development, Biologics Scale-Up, Downstream Processing, and Upstream Processing